Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,736Revenue $M7,380Net Margin (%)-1.6Z-Score1.0
Enterprise Value $M27,411EPS $-0.1Operating Margin %-4.1F-Score6
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)-6.9Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow3.8y-y EBITDA Growth Rate %-73.7ROA % (ttm)-0.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-1.8Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,331ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 17.8428%Reduce -97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 17.8428%Add 16.36%59,624,800
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 17.8429%Add 19.88%51,242,050
BSXRay Dalio 2014-09-30 Buy 0.01%$11.92 - $13.29
($12.59)
$ 17.8429%New holding61,384
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 17.8429%Sold Out0
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 17.8427%Reduce -23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 17.8427%Add 16.19%42,743,200
BSXRay Dalio 2014-03-31 Reduce-0.01%$11.91 - $13.98
($13.08)
$ 17.8427%Reduce -70.15%36,884
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 17.8434%Reduce -36.64%8,533,099
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 17.8434%Add 17.65%2,000,000
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 17.8434%Reduce -22.34%45,938,468
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 17.8434%New holding123,584
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 17.8434%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 17.8439%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 17.8439%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 17.8439%Reduce -15.74%38,240,700
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 17.8439%Reduce -69.22%18,744
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 17.8439%Sold Out0
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 17.8452%Reduce -96.31%624,088
BSXDodge & Cox 2013-06-30 Reduce-0.14%$7.09 - $9.64
($8.48)
$ 17.8452%Reduce -14.79%81,801,130
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pierce David ASVP and President, Endoscopy 2015-03-20Sell18,050$18-3.11view
Phalen Michael P.EVP & President, MedSurg 2015-03-20Sell46,085$17.94-2.79view
Phalen Michael P.EVP & President, MedSurg 2015-03-16Sell30,022$17.181.51view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-03-13Sell3,830$16.843.56view
Pierce David ASVP and President, Endoscopy 2015-03-09Sell2,561$16.545.44view
Phalen Michael P.EVP & President, MedSurg 2015-03-03Sell12,768$16.793.87view
Prange KarenSVP&Pres, Uro & Women's Health 2015-03-03Sell2,492$16.793.87view
Pierce David ASVP and President, Endoscopy 2015-03-03Sell8,983$16.793.87view
Phalen Michael P.EVP & President, MedSurg 2015-02-27Sell1,819$16.83.81view
Prange KarenSVP&Pres, Uro & Women's Health 2015-02-27Sell1,307$16.83.81view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
    Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Oct 17 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jul 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jun 26 2014 


    More From Other Websites
    Boston Scientific's First Implant of WATCHMAN Heart Device - Analyst Blog Mar 26 2015
    Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial... Mar 24 2015
    Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial... Mar 24 2015
    Southland surgeons implant Watchman heart device after it gets FDA OK Mar 23 2015
    Boston Scientific Is 'Riding The Wave Of Business Improvement' Mar 20 2015
    Top Analyst Upgrades and Downgrades: Carnival, Ericsson, Honeywell, Pier 1, Tesoro, Trimble and More Mar 20 2015
    Boston Scientific's Heart Device Wins FDA Nod, CE Mark - Analyst Blog Mar 19 2015
    Box nabs US government IT executive Mar 19 2015
    Is St. Jude Medical Facing Palpitations? Mar 19 2015
    Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names Mar 18 2015
    Oracle shares rise after earnings, dividend increase Mar 17 2015
    Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System Mar 17 2015
    Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System Mar 17 2015
    Boston Scientific Up on FDA Nod for WATCHMAN Device - Analyst Blog Mar 17 2015
    Boston Scientific (BSX) Stock Gain Continues Today on FDA Stroke Prevention Device Approval Mar 17 2015
    Stocks Take A Quiet Stumble; Boston Scientific, Adobe Advance Mar 17 2015
    Cardiology stocks with a pulse Mar 16 2015
    Watchman device approval boosts Boston Scientific Mar 16 2015
    Boston Scientific Surges Following Watchman News Mar 16 2015
    Boston Scientific (BSX) Stock Higher Today After FDA Approves Stroke Prevention Device Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK